预防前列腺穿刺并发症:增强还是拭子?
基于宾夕法尼亚泌尿区域协作数据库的11940例前列腺穿刺数据,比较三种抗生素预防路径的感染并发症风险。培养导向路径较医生经验用药路径感染并发症风险降低84%(OR=0.159,95%CI=[0.074,0.344],P<0.001),增强路径与经验用药无差异。结论支持将培养导向抗生素预防纳入临床指南。
要点
- 培养导向抗生素预防较经验用药显著降低穿刺后感染并发症风险84%。
- 增强抗生素路径与医生经验用药路径在感染并发症上无差异。
- 培养导向策略针对耐药菌并减少未来耐药风险。
核心结论
- 经直肠前列腺穿刺采用培养导向抗生素预防较其他策略显著减少感染并发症。
研究设计与样本
- 基于宾夕法尼亚泌尿区域协作前瞻性数据库的回顾性分析,纳入11940例前列腺穿刺。
主要发现
- 11940例穿刺中120例出现感染结局,培养导向3246例、增强1446例、医生经验用药7207例。
- 培养导向路径较医生经验用药路径任何感染结局风险降低84%(OR=0.159,95%CI=[0.074,0.344],P<0.001)。
- 增强路径与医生经验用药路径感染并发症无差异。
关键数值与推荐
- 感染并发症定义为穿刺后一个月内发热、尿路感染或脓毒症。
- 培养导向路径OR=0.159,95%CI=[0.074,0.344],P<0.001(对比医生经验用药)。
临床怎么用
- 经直肠前列腺穿刺应优先采用培养导向抗生素预防以降低感染并发症。
- 培养导向策略有助于针对耐药菌并减少未来耐药风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To use data from a large, prospectively- acquired regional collaborative database to compare the risk of infectious complications associated with three American Urologic Association- recommended antibiotic prophylaxis pathways, including culture-directed or augmented antibiotics, following prostate biopsy. METHODS: Data on prostate biopsies and outcomes were collected from the Pennsylvania Urologic Regional Collaborative, a regional quality collaborative working to improve the diagnosis and treatment of prostate cancer. Patients were categorized as receiving one of three prophylaxis pathways: culture-directed, augmented, or provider-discretion. Infectious complications included fever, urinary tract infections or sepsis within one month of biopsy. Odds ratios of infectious complication by pathway were determined, and univariate and multivariate analyses of patient and biopsy characteristics were performed. RESULTS: 11,940 biopsies were included, 120 of which resulted in infectious outcomes. Of the total biopsies, 3246 used "culture-directed", 1446 used "augmented" and 7207 used "provider-discretion" prophylaxis. Compared to provider-discretion, the culture-directed pathway had 84% less chance of any infectious outcome (OR= 0.159, 95% CI = [0.074, 0.344], P < 0.001). There was no difference in infectious complications between augmented and provider-discretion pathways. CONCLUSIONS: The culture-directed pathway for transrectal prostate biopsy resulted in significantly fewer infectious complications compared to other prophylaxis strategies. Tailoring antibiotics addresses antibiotic-resistant bacteria and reduces future risk of resistance. These findings make a strong case for incorporating culture-directed antibiotic prophylaxis into clinical practice guidelines to reduce infection following prostate biopsies.
引用
- Glick L, Vincent SA, Squadron D, et al. Preventing Prostate Biopsy Complications: to Augment or to Swab? Urology. 2021. PMID: 33878333. doi:10.1016/j.urology.2021.02.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。